Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

SpyGlass Pharma Inc. has raised a $75 million Series D round that brings the company closer to commercializing its ...

Healthcare generates massive volumes of data daily – from electronic health records and insurance claims to genomic research ...

With funding cuts threatening global immunization, philanthropic organizations are stepping up but warn they can’t fill the ...

THE agriculture sector is recovering from recent setbacks and will likely post significant gains including record palay ...

Five individuals (3.3%) experienced peak aminotransferase levels greater than five times the ULN, and two (1.3%) had ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

Mustang Bio shares are trading sharply higher Monday afternoon. The FDA granted Orphan Drug Designation to its cell therapy, ...

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting ...

Long believed to have minimal long-term side effects, cannabis has been found to increase the risk of damage to a vital organ ...